Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

SELL
$902.69 - $993.35 $598,483 - $658,591
-663 Reduced 85.33%
114 $109,000
Q4 2023

Feb 14, 2024

BUY
$775.18 - $881.7 $517,820 - $588,975
668 Added 612.84%
777 $682,000
Q3 2023

Nov 07, 2023

BUY
$692.45 - $844.37 $75,477 - $92,036
109 New
109 $89,000
Q1 2023

May 12, 2023

BUY
$680.49 - $826.97 $400,808 - $487,085
589 New
589 $483,000
Q3 2022

Nov 07, 2022

BUY
$573.97 - $724.32 $79,781 - $100,680
139 New
139 $95,000
Q1 2022

May 16, 2022

SELL
$595.12 - $698.43 $324,935 - $381,342
-546 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$543.48 - $670.97 $1.81 Million - $2.23 Million
-3,330 Reduced 85.91%
546 $344,000
Q3 2021

Nov 09, 2021

SELL
$574.03 - $680.96 $7.98 Million - $9.47 Million
-13,903 Reduced 78.2%
3,876 $2.35 Million
Q2 2021

Aug 12, 2021

BUY
$472.8 - $558.54 $8.02 Million - $9.47 Million
16,957 Added 2062.9%
17,779 $9.93 Million
Q1 2021

May 14, 2021

SELL
$446.73 - $548.2 $1.66 Million - $2.04 Million
-3,727 Reduced 81.93%
822 $388,000
Q4 2020

Feb 12, 2021

SELL
$478.3 - $607.98 $4,783 - $6,079
-10 Reduced 0.22%
4,549 $2.2 Million
Q3 2020

Nov 16, 2020

BUY
$544.75 - $658.21 $2.48 Million - $3 Million
4,559 New
4,559 $2.55 Million
Q3 2019

Nov 12, 2019

SELL
$273.46 - $318.39 $2.46 Million - $2.86 Million
-8,978 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$299.6 - $414.82 $1.46 Million - $2.02 Million
4,878 Added 118.98%
8,978 $2.81 Million
Q1 2019

May 13, 2019

SELL
$372.08 - $439.57 $2.12 Million - $2.5 Million
-5,691 Reduced 58.12%
4,100 $1.68 Million
Q4 2018

Feb 13, 2019

BUY
$335.82 - $403.04 $2.93 Million - $3.52 Million
8,730 Added 822.81%
9,791 $3.66 Million
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $372,559 - $433,429
1,061 New
1,061 $428,000
Q1 2018

May 11, 2018

SELL
$315.82 - $393.78 $1.19 Million - $1.49 Million
-3,778 Closed
0 $0
Q4 2017

Feb 12, 2018

BUY
$358.63 - $469.95 $1.35 Million - $1.78 Million
3,778
3,778 $1.42 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.